2019’s (Midyear) Stocks To Watch

David Kass’s six stocks to watch in 2019 have been on a hot streak. Now, he recommends keeping your eye on four others, as well.

Why This Year’s Warren Buffett Charity Lunch Is Different

One imagines that Warren Buffett has some pretty interesting lunch meetings. But this one is likely to be more interesting than most.

Break Up Facebook? What Would That Even Look Like?

The headline on Facebook co-founder Chris Hughes’ New York Times op-ed article made his position clear. 'It’s Time To Break Up Facebook.' But break up Facebook? How?

Warren Buffett an ‘Idiot’?

Famed investor and Berkshire Hathaway CEO Warren Buffett says he wishes he had bought shares early in some of the giants of tech, the so-called FAANG companies whose stocks have consistently outperformed the S&P. Here's why he missed the boat.

Five Reasons To Steer Clear of 2019’s Mega IPOs

In what’s poised to be a big year for big-name IPOs, Kass lists five reasons to ease up on the gas pedal and proceed with caution.

Why Do a Corporate Spinoff?

Why would a company with a portfolio of brands seek to do a corporate spinoff? And what does the move mean for shareholders?

Stock Buybacks Are Not the Enemy

Stock buybacks have found themselves in various crosshairs of late, and it’s got Maryland Smith’s David Kass shaking his head. Buybacks, he says, are not the problem.

Stocks To Watch in the Year Ahead

Like the big man in the North Pole, Maryland Smith’s David Kass spends the waning weeks of the year making a list and checking it twice.

Survive Holiday Travel, With Tips From the Experts

Maryland Smith faculty share their best travel hacks, from traveling early to the best ways to tolerate traffic, to make your holidays easier.

What To Watch As Pharma Prices Take Center Stage

Pharmaceutical prices are poised to become a central issue for the next Congress, potentially forcing lawmakers to consider at least two factors that coincide with America’s higher-than-average drug prices.

Back to Top